HIV positive children can now benefit from an anti-retroviral drug designed specially for them. Triomune Baby and Junior were developed with funding from the European and Developing Countries Clinical Trials Partnership (EDCTP).
The US Food and Drug Administration (FDA) recently gave its tentative approval for the drug, paving the way for it to receive prequalification status from the World Health Organisation (WHO) and making it available for distribution under the President's Emergency Plan for AIDS Relief (PEPFAR) and Clinton Foundation programmes. read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment